Anzeige
Mehr »
Mittwoch, 11.02.2026 - Börsentäglich über 12.000 News
Breaking News: Pacifica meldet neue hochgradige Entdeckung und genau deshalb kann der Markt das nicht ignorieren
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
112 Leser
Artikel bewerten:
(0)

Alfardan Medical with Northwestern Medicine select Allscripts

Allscripts first client in Qatar to provide first-of-its-kind ambulatory care services

CHICAGO, March 11, 2019have selected Allscripts to provide ambulatory care services for the launch of its new project, Alfardan Medical with Northwestern Medicine. The project is a part of Allscripts expansion in the Middle East and will provide ambulatory care services including Sunrise Ambulatory, Sunrise Surgery, Sunrise Radiology, Allscripts Clinical Performance Management, Allscripts Lab and iPro Anesthesia.

Based in Burj Alfardan, Lusail, Alfardan Medical with Northwestern Medicine is the first of Alfardan Group's investments in the health sector, as part of its social responsibility toward the State of Qatar and its vision to develop projects that will contribute to the realization of the Qatar National Vision 2030. Alfardan Medical with Northwestern Medicine will offer high quality healthcare and a range of multidisciplinary medical specializations in a unique clinical environment.

Used by healthcare organizations across the globe, Allscripts Sunrise is a fully integrated electronic health record that connects all aspects of care, including ambulatory, surgical, radiology, and laboratory services. Built to enable efficient and safe care, Sunrise is a physician-friendly, evidence-based single platform with integrated analytics that helps deliver true personalized medicine. Sunrise supports all core care venues across the enterprise by delivering a single patient record, and features patient-centric capabilities that increase access and convenience for the consumer.

"Alfardan Group has built its reputation on offering our clients a lifestyle in keeping with the quality and premium services that they value," said Omar Hussain Alfardan, President and Chief Executive Officer of Alfardan Group. "We believe Allscripts is the suitable partner to help us deliver world-class integrated healthcare to Qatar."

"We are pleased to have the opportunity to partner with Alfardan Group and Northwestern Medicine in its new project," said Alan Fowles, President of Allscripts Global. "With the help of this new partnership in the Middle East, we can demonstrate the value of Allscripts commitment to open, connected communities of care to its people and across the globe."

About Allscripts
Allscripts, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

About AMNM

About Alfardan Medical with Northwestern Medicine
Medical with Northwestern Medicine (AMNM) is an ambulatory care center that provides high quality, multidisciplinary medical specializations, based in Burj Alfardan, Lusail. AMNM is an international collaboration between Alfardan Group and Northwestern Medicine (Chicago, U.S.A.). They each share a vision and a set of guiding values for the establishment, execution and operation of AMNM.

For more information, please visit the AMNM website at www.amnm.com

© 2019 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.

Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.

For more information contact:

Investors:
Stephen Shulstein
312-386-6735
Stephen.Shulstein@allscripts.com

Media:
Concetta Rasiarmos
312-447-2466
concetta.rasiarmos@allscripts.com

© 2019 GlobeNewswire (Europe)
Favoritenwechsel
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.